TG THERAPEUTICS INC TGTX
ASignal's systematic analysis rates TGTX as Neutral.
Reflects the latest available analysis · analyzed Nov 11, 2026
The case on TGTX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (60.7% YoY)
- High gross margin (82.74%) indicating pricing power
- Positive MACD histogram showing strengthening momentum
- Price trading above both SMA20 and SMA50, confirming uptrend
- High growth score (0.9) reflecting strong top-line expansion
- RSI at 76.46 indicating overbought conditions
- Negative earnings growth (down 85.6% YoY)
- High P/E ratio (95.91x) and forward P/E (24.29x) suggesting rich valuation
- Debt-to-equity ratio of 1.25x, above ideal threshold of 0.5
- Return on equity and return on assets not available, limiting fundamental visibility
See the full verdict on TGTX
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TGTX
Most investors never get a second opinion, let alone several. ASignal runs TGTX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.